Well you can't accuse abt of not trying to sell it's products! Should it be that difficult to sell a quality product? I'm giving them until the 2019 q2 sales numbers then that's it.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
